|
Division of Hematologic Malignancies & Cellular Therapy Updates Part 1 |
09/13/2023 - 8:00am to 9:00am EDT |
|
Developments in the Management of Early-Stage Resectable NSCLC without Targetable Mutations & An unusual case of lung cancer: MALT lymphoma in a young |
12/06/2023 - 8:00am to 9:00am EST |
|
Circulating Tumor DNA as a Non-Invasive Biomarker in Solid Tumor Oncology |
04/05/2023 - 8:00am to 9:00am EDT |
|
CAR T-Cell Therapy for Pediatric B-ALL |
05/17/2023 - 8:00am to 9:00am EDT |
|
Breaking Bad B Cells: Identifying Novel Targets in Chronic GVHD |
01/04/2023 - 8:30am to 9:00am EST |
|
Atlas of Blood Cancer Genomes: Our 10,000 Patient Odyssey To Personalized Genomics |
01/18/2023 - 8:00am to 9:00am EST |
|
Acquired von Willebrand syndrome / Immunotherapy or hospice? |
06/21/2023 - 8:00am to 9:00am EDT |
|
A Role for Androgen Receptor in Hepatocellular Carcinoma & Vanishing Biomarker: A Case of HER2-positive Early Breast Cancer |
10/18/2023 - 8:00am to 9:00am EDT |
|
A Review on Factor XI Inhibitors and Potential for Treatment of Cancer-Associated Thrombosis / Acute Promyelocytic Leukemia: Historical awareness, Building Trust and Empowering Patients |
06/14/2023 - 8:00am to 9:00am EDT |
|
A Rare Treatment Related Toxicity in Multiple Myeloma - A Case Study and Brief Literature Review/A case-based discussion of POEMS syndrome |
12/20/2023 - 8:00am to 9:00am EST |
Facebook
X
LinkedIn
Forward